After announcing in March that it was seeking “strategic alternatives” for its future, Seattle publicly-traded biotechnology company Neoleukin Therapeutics is… Read More
University of Washington spinout Wavely Diagnostics, which is developing a smartphone app to detect ear infections, raised $1.35 million. The… Read More
Seattle-based startup Heard, which supports mental health professionals with financial software and services, raised $15 million in new funding. Heard… Read More
University of Washington spinout AltPep, which is developing tests and treatments for Alzheimer’s and Parkinson’s disease, completed a $52.9 million… Read More
Washington state lawmakers recently extended a law that loosens restrictions on audio-only healthcare delivery, while they wait for the results… Read More
Healthcare company 98point6 landed additional investment to support its transition to a licensor of virtual care solutions, following a move to… Read More
Seagen fielded multiple offers before agreeing to a whopping $43 billion acquisition by pharma giant Pfizer. The Seattle-area company revealed… Read More
Vancouver, B.C.-based biotech company Aspect Biosystems inked a partnership worth potentially more than $2.6 billion with Danish biopharma giant Novo… Read More
The news: Sonoma Biotherapeutics is partnering with Regeneron to co-develop cell therapies for Crohn’s disease and other autoimmune conditions. The… Read More
